Sometimes, a breakthrough matters not only because of what it does for patients today, but because of what it makes possible for tomorrow.
|Articles|August 13, 2013
- July/August 2013
- Volume 4
- Issue 4
September-October 2013 Meetings
Advertisement
SEPTEMBER
10th Annual Oncology Summit
September 18-19, 2013
Hyatt Regency Baltimore
Baltimore, Maryland
Meeting Highlights: Join your colleagues in specialty pharmacy to discuss 340b pricing, the oncology payer landscape, the oncology pipeline, self-administered specialty drugs, and the medical management of end-of-life treatment.
Register: www.cvent.com/events/10th-annualoncology-summit/event-summary-eac1d5bbb2ab-4dcd9303078d93eba2bb.aspx
Pinsonault Managed Markets Summit Fall 2013
September 18-20, 2013
Hotel Del Coronado
Coronado, California
Meeting Highlights: Pharmacy managers and directors will benefit from breakout sessions with leading health care organization executives on integrated delivery networks, patient-centered medical homes, accountable care organizations, pay for performance, Medicaid, Managed Medicaid, and exchanges.
Register: www.pinsonault.com/events-mms.aspx
NCCN 8th Annual Congress: Hematologic Malignancies
September 20-21, 2013
New York Marriott Marquis
New York, New York
Meeting Highlights: Targeted therapies and oral treatments will be the focus of this 2-day congress, along with new approaches to the use of drugs, biologics, and diagnostics.
Register: www.nccn.org/professionals/meetings/hematological/default.asp
OCTOBER
National Association of Specialty Pharmacy (NASP) Strategic Business Exchange
October 14-16, 2013
Hyatt Regency San Antonio Riverwalk
San Antonio, Texas
Meeting Highlights: Topics will span bioethical issues in specialty pharmacy, the specialty patient of the future, and the impact of the Affordable Care Act on specialty pharmacy.
Register: http://meetings.nasprx.org
Therigy Specialty Pharmacy Leadership Congress
October 22-24, 2013
The Peabody
Orlando, Florida
Meeting Highlights: This is an invitation-only gathering of industry leaders from pharmacies, pharmaceutical manufacturers, health systems, and payers in the specialty pharmaceutical industry who will participate in facilitated working sessions and educational forums.
Register: http://therigycongress.com
Articles in this issue
about 13 years ago
Growth Hormone Therapy: A Specialty Pharmacy Overviewabout 13 years ago
Many Antibody-Positive Patients Are Never HCV RNA Testedabout 13 years ago
HCV and OBI Co-Infections May Increase Poor Outcomesabout 13 years ago
RSV Infections in Infancy Linked to Wheezing in Childhoodabout 13 years ago
Triple Therapy May Cause More Adverse Reactions in HCV Patientsabout 13 years ago
Adding a Specialty Pharmacy to Your Retail Brandabout 13 years ago
How Smartphones Will Transform Your Patient Relationshipsabout 13 years ago
Who Really Knows Best?about 13 years ago
Distribution Networks: Why Limit Them?Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
SubscribeAdvertisement
Related to this article
Pharmacogenomic-guided prescribing uses genetic data to protect patients from dangerous toxicities and get them the right drug at the right dose from the start.
As accessible health care providers, pharmacists can raise awareness about the proper use of OTC blood glucose meters and continuous glucose monitoring devices.
Growing evidence points to gallstones and cholecystitis as an underrecognized risk of GLP-1 RA therapy—pharmacists are well positioned to catch it early.
As earning years peak, so do spending and responsibility—here’s where midcareer pharmacists should focus their financial decision-making.
Despite the controversy surrounding mRNA's role in the COVID-19 response, the technology's broader promise—to prevent, treat, and even cure a host of diseases—is coming into focus.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Rising Gallbladder Complications With GLP-1 Receptor Agonists Call for Closer Pharmacist Monitoring
2
What Different Communities Taught Me About Patient Care
3
Patients Report Early, Sustained Functional Gains With First-Line Zongertinib in HER2-Mutant NSCLC
4
The Value of Self-Monitoring Blood Glucose Tools in Preventing and Reducing Prediabetes and Diabetes-Related Complications
5